GELS.US Gelteq Limited Ordinary Shares

Healthcare Pharmaceuticals USA Stocks
0.3803 USD
Close of Nov 14, 2026
0.3800 2.01
Market cap
USD 4.07M
P/E
-
P/B
0.44x
ROE
-52.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Mar 2026.

Is GELS.US undervalued?

Graham number

The Graham number of Gelteq Limited Ordinary Shares cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Gelteq Limited Ordinary Shares fundamental analysis

No fundamental analysis for Gelteq Limited Ordinary Shares yet.

Gelteq Limited Ordinary Shares stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Gelteq Limited Ordinary Shares

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Full company profile